Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia

被引:11
作者
Bange, Erin [1 ]
Timlin, Colleen [1 ]
Kabel, Charlene [2 ]
Svoboda, Jakub [1 ]
Roeker, Lindsey [2 ]
Mato, Anthony R. [2 ]
机构
[1] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ctr CLL, Philadelphia, PA 19104 USA
[2] Mem Sloan Kettering Canc Ctr, Sect Hematol Oncol, Leukemia Serv, CLL Program, 1275 York Ave, New York, NY 10065 USA
关键词
CLL; Complementary and alternative medicine; Herbal medicine; Leukemia; Lymphoma; ALTERNATIVE MEDICINE USE; ORAL POLYPHENON E; RAI STAGE 0; CANCER-PATIENTS; DEATH RECEPTOR; T-CELLS; B-CELLS; COMPLEMENTARY; CURCUMIN; INHIBITION;
D O I
10.1016/j.clml.2018.06.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Complementary and alternative medicine (CAM) is a diverse group of medical and health care systems, practices, and products that are not generally considered part of conventional medicine. Chronic lymphocytic leukemia (CLL) is the most common leukemia diagnosed in the western hemisphere, and 16.5% to 66% of patients have reported using CAM. Most patients use spiritual/mindebody techniques and high doses of vitamins and herbs (most commonly polyphenols, including teas). We have reviewed the reported data on green tea and turmeric use in CLL patients.
引用
收藏
页码:E421 / E426
页数:6
相关论文
共 67 条
[21]   Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG [J].
Ghosh, Asish K. ;
Kay, Neil E. ;
Secreto, Charla R. ;
Shanafelt, Tait D. .
CLINICAL CANCER RESEARCH, 2009, 15 (04) :1250-1258
[22]   Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia [J].
Giannopoulos, Krzysztof ;
Schmitt, Michael ;
Kowal, Malgorzata ;
Wlasiuk, Paulina ;
Bojarska-Junak, Agnieszka ;
Chen, Jinfei ;
Rolinski, Jacek ;
Dmoszynska, Anna .
ONCOLOGY REPORTS, 2008, 20 (03) :677-682
[23]   Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors [J].
Golden, Encouse B. ;
Lam, Philip Y. ;
Kardosh, Adel ;
Gaffney, Kevin J. ;
Cadenas, Enrique ;
Louie, Stan G. ;
Petasis, Nicos A. ;
Chen, Thomas C. ;
Schoenthal, Axel H. .
BLOOD, 2009, 113 (23) :5927-5937
[24]  
Golombick T, 2015, Journal of Cancer Therapy, V6, P566, DOI DOI 10.4236/JCT.2015.67061
[25]   Molecular steps of death receptor and mitochondrial pathways of apoptosis [J].
Gupta, S .
LIFE SCIENCES, 2001, 69 (25-26) :2957-2964
[26]   Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].
Hallek, Michael ;
Cheson, Bruce D. ;
Catovsky, Daniel ;
Caligaris-Cappio, Federico ;
Dighiero, Guillaume ;
Doehner, Hartmut ;
Hillmen, Peter ;
Keating, Michael J. ;
Montserrat, Emili ;
Rai, Kanti R. ;
Kipps, Thomas J. .
BLOOD, 2008, 111 (12) :5446-5456
[27]   Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells [J].
Hayun, Rami ;
Okun, Eitan ;
Berrebi, Alain ;
Shvidel, Lev ;
Bassous, Lucette ;
Sredni, Benjamin ;
Nir, Uri .
LEUKEMIA & LYMPHOMA, 2009, 50 (04) :625-632
[28]   Complementary and alternative medicine in patients with chronic lymphocytic leukemia [J].
Hensel, Manfred ;
Zoz, Martin ;
Ho, Anthony D. .
SUPPORTIVE CARE IN CANCER, 2009, 17 (01) :47-52
[29]   Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients [J].
Hierl, Marina ;
Pfirstinger, Jochen ;
Andreesen, Reinhard ;
Holler, Ernst ;
Mayer, Stephanie ;
Wolff, Daniel ;
Vogelhuber, Martin .
ONCOLOGY, 2017, 93 (03) :157-163
[30]   Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making [J].
Hlubocky, Fay J. ;
Ratain, Mark J. ;
Wen, Ming ;
Daugherty, Christopher K. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :548-554